Our causal analyses suggested that GLP-1 RAs could alleviate certain mood disorders, which might be attributed to either the improvement of patients’ conditions following GLP-1 RA treatment, or the neuroprotective effects of GLP-1 RAs themselves on neurons. This evidence concerns the gene GCG and mood disorder.